Celestine Ravenswood
Website blocks users from accessing content
Health plans are blocking users from content. Learn how new Medicare changes impact formulary access and patient care.
User Account Blocked by Social Media Platform
HIV/AIDS relief efforts disrupted, affecting vulnerable populations with HIV infection, according to PEPFAR findings and survey results.
User access denied after system block
Patients with eye disease face worsening conditions after losing access to copay assistance for anti-VEGF drugs, study reveals.
User Blocked from Online Platform
FDA approves Merck's Lipfendra to reduce LDL cholesterol in adults with hypercholesterolemia using PCSK9 inhibitor.
User access restricted after policy breach
The FTC settlement with Caremark and Zinc Health targets pharmacy benefit managers to lower insulin costs and improve transparency for consumers.
User access denied after system block
The U.S. Medicare drug pricing policy may cut costs by matching prices in other wealthy nations, reshaping pharmaceutical research priorities.
User access denied after policy breach
Dermatologists propose ending routine blood tests for isotretinoin patients without risk factors to streamline acne treatment.
User Blocked by Service
New PBM regulations in 2026 enhance transparency. Learn how industry changes impact healthcare practices.
Service Apologizes for Blocking Users
Updated trial data shows the ALK inhibitor lorlatinib achieves record progression-free survival for lung cancer, potentially changing treatment guidelines.
User Accounts Blocked After Policy Violations
Physical inactivity is identified as the leading predictor of diabetes across U.S. counties, highlighting the urgent need for active lifestyles today.